Issue navigation
Volume 12, Issue 5, May 2018
Editorials
Top-down in the Long Term in Crohn’s Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 513–514, https://doi.org/10.1093/ecco-jcc/jjy027
Does Familial IBD Have its Own Signature?
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 515–516, https://doi.org/10.1093/ecco-jcc/jjy016
Original Articles
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn’s Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 517–524, https://doi.org/10.1093/ecco-jcc/jjy014
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 525–531, https://doi.org/10.1093/ecco-jcc/jjx154
Validation of the ‘United Registries for Clinical Assessment and Research’ [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 532–537, https://doi.org/10.1093/ecco-jcc/jjy015
Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 538–545, https://doi.org/10.1093/ecco-jcc/jjy022
Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 546–558, https://doi.org/10.1093/ecco-jcc/jjy006
Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 559–567, https://doi.org/10.1093/ecco-jcc/jjy005
Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 568–581, https://doi.org/10.1093/ecco-jcc/jjy010
Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn’s Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 582–588, https://doi.org/10.1093/ecco-jcc/jjy001
Tags:
alleles, crohn's disease, fibrosis, genes, genetics
CD16+ Macrophages Mediate Fibrosis in Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 589–599, https://doi.org/10.1093/ecco-jcc/jjx185
Review Articles
Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 600–609, https://doi.org/10.1093/ecco-jcc/jjy024
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 610–620, https://doi.org/10.1093/ecco-jcc/jjx181
Short report
Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Pages 621–626, https://doi.org/10.1093/ecco-jcc/jjy019
Letters to the Editor
Steroids and the Risk of Venous Thromboembolic Events in Inflammatory Bowel Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Page 627, https://doi.org/10.1093/ecco-jcc/jjx183
Low Doses of Azathioprine are Effective in Combination With Infliximab in Inflammatory Bowel Disease but May not be During Induction Therapy
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Page 628, https://doi.org/10.1093/ecco-jcc/jjx182
New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Page 629, https://doi.org/10.1093/ecco-jcc/jjx179
Corrigenda
Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Page 630, https://doi.org/10.1093/ecco-jcc/jjx172
Corrigendum: Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease
Journal of Crohn's and Colitis, Volume 12, Issue 5, May 2018, Page 631, https://doi.org/10.1093/ecco-jcc/jjx171
